Salveen Richter
Stock Analyst at Goldman Sachs
(4.51)
# 1,067
Out of 5,044 analysts
552
Total ratings
47.7%
Success rate
10.1%
Average return
Main Sectors:
Stocks Rated by Salveen Richter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VTRS Viatris | Maintained: Hold | $20 | $17.46 | +14.55% | 4 | Oct 9, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintained: Buy | $972 | $734.81 | +32.28% | 26 | Oct 2, 2026 | |
| QURE uniQure | Rated: Hold | $46 → $31 | $23.37 | +32.65% | 24 | Sep 30, 2026 | |
| AMGN Amgen | Reiterated: Buy | $450 | $407.27 | +10.49% | 23 | Sep 22, 2026 | |
| RAPP Rapport Therapeutics | Reiterated: Buy | $62 | $32.83 | +88.85% | 5 | Sep 22, 2026 | |
| VRTX Vertex Pharmaceuticals | Reiterated: Buy | $653 | $506.74 | +28.86% | 30 | Sep 22, 2026 | |
| IONS Ionis Pharmaceuticals | Reiterated: Hold | $56 | $44.00 | +27.27% | 20 | Sep 14, 2026 | |
| SMMT Summit Therapeutics | Reiterated: Buy | $41 | $16.69 | +145.66% | 7 | Sep 13, 2026 | |
| BRVE Braveheart Bio | Reiterated: Buy | $48 | $21.41 | +124.19% | 2 | Sep 8, 2026 | |
| RARE Ultragenyx Pharmaceutical | Reiterated: Hold | $28 → $19 | $14.75 | +28.81% | 15 | Sep 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $73 | $16.69 | +337.39% | 1 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $69 → $70 | $58.44 | +19.78% | 18 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $67 → $120 | $188.94 | -36.49% | 48 | Aug 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $4.74 | +174.26% | 7 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $48 → $55 | $55.44 | -0.79% | 17 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 | $4.12 | +69.90% | 2 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $9 | $12.12 | -25.74% | 18 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $67 → $80 | $46.21 | +73.12% | 7 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $130 | $147.50 | -11.86% | 16 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $110 → $118 | $117.14 | +0.73% | 27 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $32 | $32.48 | -1.48% | 17 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $13.84 | +138.44% | 13 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $31 | $18.49 | +67.66% | 12 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $250 | $222.82 | +12.20% | 31 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $550 | $231.18 | +137.91% | 22 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41 | $22.35 | +83.45% | 1 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $20.89 | +67.54% | 3 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $26 | $13.80 | +88.41% | 2 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 → $17 | $17.57 | -3.24% | 23 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 | $25.23 | -36.58% | 6 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $15 → $17 | $19.89 | n/a | 11 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 | $10.92 | n/a | 1 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 → $40 | $20.53 | n/a | 13 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.46 | n/a | 9 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $39 | $2.59 | n/a | 1 | Apr 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 → $30 | $18.22 | n/a | 3 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $48 → $5 | $27.37 | n/a | 8 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $66.91 | n/a | 1 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $61.46 | n/a | 1 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $53 | $57.63 | n/a | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $7 | $2.52 | n/a | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $31 | $1.54 | n/a | 10 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $225 | $211.31 | n/a | 2 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $22 | $2.99 | n/a | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $30 → $7 | $9.40 | n/a | 2 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 → $1 | $6.33 | n/a | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $9 | $4.07 | n/a | 4 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $34 → $6 | $2.89 | n/a | 4 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $28 → $30 | $4.20 | n/a | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $126 → $131 | $499.71 | n/a | 7 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $11 | $1.40 | n/a | 5 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $40 | $3.66 | n/a | 1 | Oct 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $45 → $47 | $64.79 | n/a | 2 | May 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $4 → $2 | $6.98 | n/a | 3 | Nov 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $44 → $76 | $571.38 | n/a | 3 | Oct 29, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $18 → $2 | $2.07 | n/a | 2 | Oct 15, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $0.0001 | n/a | 1 | Dec 2, 2011 |
Viatris
Oct 9, 2026
Maintained: Hold
Price Target: $20
Current: $17.46
Upside: +14.55%
Regeneron Pharmaceuticals
Oct 2, 2026
Maintained: Buy
Price Target: $972
Current: $734.81
Upside: +32.28%
uniQure
Sep 30, 2026
Rated: Hold
Price Target: $46 → $31
Current: $23.37
Upside: +32.65%
Amgen
Sep 22, 2026
Reiterated: Buy
Price Target: $450
Current: $407.27
Upside: +10.49%
Rapport Therapeutics
Sep 22, 2026
Reiterated: Buy
Price Target: $62
Current: $32.83
Upside: +88.85%
Vertex Pharmaceuticals
Sep 22, 2026
Reiterated: Buy
Price Target: $653
Current: $506.74
Upside: +28.86%
Ionis Pharmaceuticals
Sep 14, 2026
Reiterated: Hold
Price Target: $56
Current: $44.00
Upside: +27.27%
Summit Therapeutics
Sep 13, 2026
Reiterated: Buy
Price Target: $41
Current: $16.69
Upside: +145.66%
Braveheart Bio
Sep 8, 2026
Reiterated: Buy
Price Target: $48
Current: $21.41
Upside: +124.19%
Ultragenyx Pharmaceutical
Sep 4, 2026
Reiterated: Hold
Price Target: $28 → $19
Current: $14.75
Upside: +28.81%
Sep 1, 2026
Reiterated: Buy
Price Target: $73
Current: $16.69
Upside: +337.39%
Aug 31, 2026
Reiterated: Hold
Price Target: $69 → $70
Current: $58.44
Upside: +19.78%
Aug 19, 2026
Rated: Hold
Price Target: $67 → $120
Current: $188.94
Upside: -36.49%
Aug 11, 2026
Reiterated: Buy
Price Target: $13
Current: $4.74
Upside: +174.26%
Aug 10, 2026
Rated: Hold
Price Target: $48 → $55
Current: $55.44
Upside: -0.79%
Aug 6, 2026
Reiterated: Hold
Price Target: $7
Current: $4.12
Upside: +69.90%
Aug 6, 2026
Reiterated: Sell
Price Target: $9
Current: $12.12
Upside: -25.74%
Aug 5, 2026
Rated: Buy
Price Target: $67 → $80
Current: $46.21
Upside: +73.12%
Aug 3, 2026
Reiterated: Hold
Price Target: $130
Current: $147.50
Upside: -11.86%
Jul 29, 2026
Reiterated: Hold
Price Target: $110 → $118
Current: $117.14
Upside: +0.73%
Jul 21, 2026
Reiterated: Hold
Price Target: $32
Current: $32.48
Upside: -1.48%
Jul 20, 2026
Reiterated: Buy
Price Target: $33
Current: $13.84
Upside: +138.44%
Jul 20, 2026
Reiterated: Buy
Price Target: $22 → $31
Current: $18.49
Upside: +67.66%
Jul 13, 2026
Reiterated: Buy
Price Target: $250
Current: $222.82
Upside: +12.20%
Jun 25, 2026
Reiterated: Buy
Price Target: $550
Current: $231.18
Upside: +137.91%
Jun 1, 2026
Reiterated: Buy
Price Target: $41
Current: $22.35
Upside: +83.45%
May 13, 2026
Reiterated: Buy
Price Target: $35
Current: $20.89
Upside: +67.54%
Apr 9, 2026
Reiterated: Buy
Price Target: $14 → $26
Current: $13.80
Upside: +88.41%
Feb 25, 2026
Reiterated: Hold
Price Target: $19 → $17
Current: $17.57
Upside: -3.24%
Oct 30, 2025
Reiterated: Hold
Price Target: $16
Current: $25.23
Upside: -36.58%
Aug 7, 2025
Reiterated: Sell
Price Target: $15 → $17
Current: $19.89
Upside: n/a
Aug 7, 2025
Reiterated: Hold
Price Target: $19
Current: $10.92
Upside: n/a
Jan 28, 2025
Reiterated: Buy
Price Target: $46 → $40
Current: $20.53
Upside: n/a
Dec 19, 2024
Rated: Hold
Price Target: n/a
Current: $8.46
Upside: n/a
Apr 2, 2024
Initiated Coverage: Hold
Price Target: $39
Current: $2.59
Upside: n/a
Mar 5, 2024
Reiterated: Buy
Price Target: $37 → $30
Current: $18.22
Upside: n/a
Feb 16, 2024
Reiterated: Hold
Price Target: $48 → $5
Current: $27.37
Upside: n/a
Jan 8, 2024
Reiterated: Buy
Price Target: n/a
Current: $66.91
Upside: n/a
Jan 5, 2024
Reiterated: Buy
Price Target: n/a
Current: $61.46
Upside: n/a
Jul 31, 2023
Reiterated: Buy
Price Target: $53
Current: $57.63
Upside: n/a
Jun 12, 2023
Reiterated: Sell
Price Target: $7
Current: $2.52
Upside: n/a
Mar 1, 2023
Reiterated: Buy
Price Target: $32 → $31
Current: $1.54
Upside: n/a
Feb 24, 2023
Reiterated: Buy
Price Target: $225
Current: $211.31
Upside: n/a
Nov 14, 2022
Initiated Coverage: Hold
Price Target: $22
Current: $2.99
Upside: n/a
Nov 11, 2022
Downgraded: Hold
Price Target: $30 → $7
Current: $9.40
Upside: n/a
Nov 10, 2022
Reiterated: Hold
Price Target: $2 → $1
Current: $6.33
Upside: n/a
Nov 9, 2022
Reiterated: Hold
Price Target: $8 → $9
Current: $4.07
Upside: n/a
Nov 3, 2022
Reiterated: Hold
Price Target: $34 → $6
Current: $2.89
Upside: n/a
Mar 4, 2021
Upgraded: Buy
Price Target: $28 → $30
Current: $4.20
Upside: n/a
Mar 1, 2021
Reiterated: Hold
Price Target: $126 → $131
Current: $499.71
Upside: n/a
Nov 9, 2020
Reiterated: Sell
Price Target: $11
Current: $1.40
Upside: n/a
Oct 28, 2020
Downgraded: Hold
Price Target: $40
Current: $3.66
Upside: n/a
May 8, 2020
Reiterated: Hold
Price Target: $45 → $47
Current: $64.79
Upside: n/a
Nov 13, 2019
Reiterated: Sell
Price Target: $4 → $2
Current: $6.98
Upside: n/a
Oct 29, 2013
Rated: Hold
Price Target: $44 → $76
Current: $571.38
Upside: n/a
Oct 15, 2013
Downgraded: Hold
Price Target: $18 → $2
Current: $2.07
Upside: n/a
Dec 2, 2011
Initiated Coverage: Buy
Price Target: $13
Current: $0.0001
Upside: n/a